Andrew J. Carroll

31.9k citations

251 papers · 12.5k indexed · 4 hit papers · h-index 57

Hematology top 0.02%
- Acute Myeloid Leukemia Research 123
- Chronic Myeloid Leukemia Treatments 73
Public Health, Environmental and Occupational Health top 0.05%
- Acute Lymphoblastic Leukemia research 152
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 26
- Genomic variations and chromosomal abnormalities 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 17
Pediatrics, Perinatology and Child Health top 0.2%
- Childhood Cancer Survivors' Quality of Life 53
Cancer Research top 1%
- Cancer Genomics and Diagnostics 13

Co-authors: Clara D. Bloomfield Krzysztof Mrózek Richard A. Larson Jonathan E. Kolitz Michael J. Borowitz Meenakshi Devidas Stephen P. Hunger Guido Marcucci
Cited by: Hematology Public Health, Environmental and Occupational Health Genetics
Journals: Science (1 paper)New England Journal of Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States Canada Germany

In The Last Decade

Andrew J. Carroll

240 papers receiving 12.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Andrew J. Carroll

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Carroll more than expected).

Fields of papers citing papers by Andrew J. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Carroll. The network helps show where Andrew J. Carroll may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew J. Carroll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Carroll Line = papers co-authored together Andrew J. Carroll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adolescent Depression and Cognition Risk for Suicide: An Investigation of Risk Factors and Gene Environment Interactions Brain and Behavior ·Stefanie R. Pilkay,D. Halevy,D. Femia,Steven M. Holland,Stephanie Heiland,Andrew J. Carroll,Sara Nunes,Tara Veerman,Leah Dudak	2025	1
2	Association of social deprivation with survival in younger adult patients with AML: an Alliance study Blood Advances ·Melanie Rebechi,Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Alice S. Mims,James S. Blachly,Shelley Orwick,Karilyn Larkin,Christopher C. Oakes,Andrew Hantel,Andrew J. Carroll,William Blum,Bayard L. Powell,Geoffrey L. Uy,Richard M. Stone,Richard A. Larson,John C. Byrd,Electra D. Paskett,Jesse J. Plascak,Ann‐Kathrin Eisfeld	2023	5
3	Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse Journal of Clinical Oncology ·Laura Hogan,Patrick A. Brown,Lingyun Ji,Xinxin Xu,Meenakshi Devidas,Teena Bhatla,Michael J. Borowitz,Elizabeth A. Raetz,Andrew J. Carroll,Nyla A. Heerema,Gerhard Zugmaier,Elad Sharon,M. Brooke Bernhardt,Stephanie Terezakis,Lia Gore,James A. Whitlock,Stephen P. Hunger,Mignon L. Loh	2023	33
4	Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study Leukemia ·Krzysztof Mrózek,Jessica Kohlschmidt,James S. Blachly,Deedra Nicolet,Andrew J. Carroll,Kellie J. Archer,Alice S. Mims,Karilyn Larkin,Shelley Orwick,Christopher C. Oakes,Jonathan E. Kolitz,Bayard L. Powell,William Blum,Guido Marcucci,Maria R. Baer,Geoffrey L. Uy,Wendy Stock,John C. Byrd,Ann‐Kathrin Eisfeld	2023	31
5	Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232 Leukemia ·Michael J. Burke,Meenakshi Devidas,Zhiguo Chen,Wanda L. Salzer,Elizabeth A. Raetz,Karen R. Rabin,Nyla A. Heerema,Andrew J. Carroll,Julie M. Gastier‐Foster,Michael J. Borowitz,Brent L. Wood,Naomi Winick,William L. Carroll,Stephen P. Hunger,Mignon L. Loh,Eric Larsen	2021	12
6	Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331 Journal of Clinical Oncology ·Leonard A. Mattano,Meenakshi Devidas,Kelly W. Maloney,Cindy Wang,Alison M. Friedmann,Patrick J. Buckley,Michael J. Borowitz,Andrew J. Carroll,Julie M. Gastier‐Foster,Nyla A. Heerema,Nina S. Kadan‐Lottick,Yousif Matloub,David T. Marshall,Linda C. Stork,Mignon L. Loh,Elizabeth A. Raetz,Brent L. Wood,Stephen P. Hunger,William L. Carroll,Naomi Winick	2021	22
7	HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions Leukemia ·Elspeth A. Bruford,Cristina R. Antonescu,Andrew J. Carroll,Arul M. Chinnaiyan,Ian A. Cree,Nicholas C.P. Cross,Raymond Dalgleish,Robert Peter Gale,Christine J. Harrison,Rosalind J. Hastings,Jean‐Loup Huret,Bertil Johansson,Michelle Le Beau,Cristina Mecucci,Fredrik Mertens,Roel G.W. Verhaak,Felix Mitelman	2021	47
8	Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932 Blood ·Anne Angiolillo,Reuven J. Schore,John A. Kairalla,Meenakshi Devidas,Karen R. Rabin,Patrick A. Zweidler‐McKay,Michael J. Borowitz,Brent L. Wood,Andrew J. Carroll,Nyla A. Heerema,Mary V. Relling,Ashley R. Lane,Kelly W. Maloney,Cindy Wang,William L. Carroll,Naomi Winick,Elizabeth A. Raetz,Mignon L. Loh,Stephen P. Hunger	2019	4
9	Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia Molecular Cancer Therapeutics ·Dimitrios Papaioannou,Deedra Nicolet,Hatice Gülçin Özer,Krzysztof Mrózek,Stefano Volinia,Paolo Fadda,Andrew J. Carroll,Jessica Kohlschmidt,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,John C. Byrd,Ramiro Garzon,Clara D. Bloomfield	2019	12
10	Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131 Cancer ·Wanda L. Salzer,Michael J. Burke,Meenakshi Devidas,Si Chen,Lia Gore,Eric Larsen,Michael J. Borowitz,Brent L. Wood,Nyla A. Heerema,Andrew J. Carroll,Joanne M. Hilden,Mignon L. Loh,Elizabeth A. Raetz,Naomi Winick,William L. Carroll,Stephen P. Hunger	2017	39
11	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,Sofia E. Maharry,Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	2017	0
12	Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,James S. Blachly,Christopher J. Walker,Deedra Nicolet,Shelley Orwick,Andrew J. Carroll,Richard M. Stone,Eunice S. Wang,Jonathan E. Kolitz,Bayard L. Powell,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	2017	0
13	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality Cancer Research ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Stefano Volinia,James S. Blachly,Deedra Nicolet,Christopher C. Oakes,Karl Kroll,Shelley Orwick,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Albert de la Chapelle,Clara D. Bloomfield	2016	16
14	Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331 Blood ·Leonard A. Mattano,Meenakshi Devidas,Alison M. Friedmann,Elizabeth A. Raetz,Mignon L. Loh,Patrick J. Buckley,Michael J. Borowitz,Andrew J. Carroll,Julie M. Gastier‐Foster,Nyla A. Heerema,Nina S. Kadan‐Lottick,Yousif Matloub,David T. Marshall,Linda C. Stork,Brent L. Wood,Naomi Winick,Stephen P. Hunger,William L. Carroll,Kelly W. Maloney	2014	13
15	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Blood ·Richard C. Harvey,Charles G. Mullighan,I‐Ming Chen,Walker Wharton,Fady M. Mikhail,Andrew J. Carroll,Huining Kang,Wei Liu,Kevin K. Dobbin,Malcolm A. Smith,William L. Carroll,Meenakshi Devidas,W. Paul Bowman,Bruce M. Camitta,Gregory H. Reaman,Stephen P. Hunger,James R. Downing,Cheryl L. Willman	2010	395
16	Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study Journal of Clinical Oncology ·Heiko Becker,Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Dean Margeson,Susan P. Whitman,Yue-Zhong Wu,Sebastian Schwind,Peter Paschka,Bayard L. Powell,Thomas H. Carter,Jonathan E. Kolitz,Meir Wetzler,Andrew J. Carroll,Maria R. Baer,Michael A. Caligiuri,Richard A. Larson,Clara D. Bloomfield	2009	241
17	Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Journal of Clinical Oncology ·Kirk R. Schultz,W. Paul Bowman,Alexander Aledo,William B. Slayton,Harland N. Sather,Meenakshi Devidas,Chenguang Wang,Stella M. Davies,Paul S. Gaynon,Michael E. Trigg,Robert Rutledge,Laura Burden,Dean Jorstad,Andrew J. Carroll,Nyla A. Heerema,Naomi Winick,Michael J. Borowitz,Stephen P. Hunger,William L. Carroll,Bruce M. Camitta	2009	436
18	Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study Journal of Clinical Oncology ·Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Tamara Vukosavljevic,Peter Paschka,Susan P. Whitman,Christian Langer,Claudia D. Baldus,Chang‐Gong Liu,Amy S. Ruppert,Bayard L. Powell,Andrew J. Carroll,Michael A. Caligiuri,Jonathan E. Kolitz,Richard A. Larson,Clara D. Bloomfield	2008	224
19	Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201 Blood ·Allen R. Chauvenet,Paul L. Martin,Meenakshi Devidas,Stephen B. Linda,Beverly Bell,Joanne Kurtzberg,Jeanette Pullen,Mark J. Pettenati,Andrew J. Carroll,Jonathan J. Shuster,Bruce M. Camitta	2007	40
20	Therapeutic Trial for Infant Acute Lymphoblastic Leukemia: The Pediatric Oncology Group Experience (POG 8493) The American journal of pediatric hematology/oncology ·Lawrence S. Frankel,J Ochs,Jonathan J. Shuster,Ronald L. Dubowy,W. Paul Bowman,Marilyn Hockenberry‐Eaton,Michael J. Borowitz,Andrew J. Carroll,C. Philip Steuber,DJ Pullen	1997	52

About Andrew J. Carroll

Andrew J. Carroll is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 251 papers that have together received 12.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (152 papers), Acute Myeloid Leukemia Research (123 papers), Chronic Myeloid Leukemia Treatments (73 papers), Childhood Cancer Survivors' Quality of Life (53 papers), Chronic Lymphocytic Leukemia Research (26 papers), Genomic variations and chromosomal abnormalities (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Hematology (8.5k citations), Public Health, Environmental and Occupational Health (6.2k citations) and Genetics (2.1k citations). Andrew J. Carroll has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Clara D. Bloomfield, Krzysztof Mrózek, Richard A. Larson, Jonathan E. Kolitz, Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger, Guido Marcucci, William L. Carroll and Bruce M. Camitta. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact